Carmel, IN, United States of America

Ming Ye

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Ming Ye in Advancing Treatments for Neurodegenerative Diseases

Introduction

Ming Ye, an innovative inventor based in Carmel, IN, has made significant contributions to the field of immunology through his work at Eli Lilly and Company. With a focus on addressing immune-mediated diseases, his inventions have the potential to change treatment modalities for conditions such as Alzheimer's Disease.

Latest Patents

Ming Ye holds two patents that underscore his expertise in developing therapeutic solutions. The first patent, titled "Compounds and methods targeting interleukin-34," centers on IL-34 antibodies and their applications in treating neurodegenerative diseases. This patent focuses on using these antibodies to combat conditions like Alzheimer's Disease and tauopathy. The second patent, "Antibodies to IL-34," shares a similar premise, emphasizing the role of IL-34 antibodies in the treatment of immune-mediated diseases, further reinforcing his commitment to advancing medical research in this critical area.

Career Highlights

At Eli Lilly and Company, Ming Ye plays a pivotal role in research and development, where his scientific and innovative abilities are vital in the quest for effective therapies. His work not only highlights his technical proficiency but also his dedication to enhancing patient outcomes through scientific advancements.

Collaborations

Ming Ye collaborates closely with notable colleagues such as Marcio Chedid and Victor H. Obungu, who contribute their expertise and insights to further the research initiatives at Eli Lilly. These collaborations foster an environment of innovation and drive forward-thinking solutions in the fight against neurodegenerative diseases.

Conclusion

Ming Ye's contributions through his patents and collaborative efforts at Eli Lilly and Company are indicative of the impact that dedicated inventors can have on the medical field. With a focus on IL-34 antibodies and their potential therapeutic applications, he is at the forefront of research aimed at improving the lives of individuals suffering from challenging immune-mediated diseases. The ongoing work of inventors like Ming Ye is essential in pushing the boundaries of medical science forward.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…